Considering that FST expression is regulated by TGF-β signaling and the likelihood that cancer cells often become unresponsive to TGF-β as oncogenesis progresses, it becomes apparent that additional mechanisms must come into play to sustain high levels of FST expression in cancer. This evidence concerns the gene TGFB1 and cancer.